Keyphrases
Breast Cancer Patients
100%
Triple-negative Breast Cancer
100%
Temporal Variation
100%
Treatment Patterns
100%
Survival Outcomes
100%
Survival Estimation
100%
Real-world Experience
100%
Treatment Survival
100%
Overall Survival
66%
Neoadjuvant Therapy
66%
Cancer Stage
66%
5-year Survival
66%
Calendar Period
66%
Latin American
33%
Single Center
33%
Health Systems
33%
High Prevalence
33%
Retrospective Cohort Study
33%
Clinical Practice Guidelines
33%
Treatment Strategy
33%
Regression Analysis
33%
High-income Countries
33%
Latinas
33%
In(III)
33%
Kaplan-Meier Method
33%
Treatment Initiation
33%
Advanced Disease
33%
Screening Practices
33%
Trial Enrollment
33%
US Hispanics
33%
Public Health Authorities
33%
Variation in Treatment
33%
Survival Treatment
33%
Medicine and Dentistry
Triple Negative Breast Cancer
100%
Overall Survival
100%
Survival Estimate
75%
Neoadjuvant Therapy
50%
Disease
25%
Public Health
25%
Prevalence
25%
Retrospective Cohort Study
25%
Kaplan Meier Method
25%
Clinical Guideline
25%
Cancer Staging
25%
Stage 1 Cancer
25%
Stage 3 Cancer
25%
Pharmacology, Toxicology and Pharmaceutical Science
Overall Survival
100%
Triple Negative Breast Cancer
100%
Cancer Staging
50%
Disease
25%
Malignant Neoplasm
25%
Prevalence
25%
Cohort Study
25%
Agricultural and Biological Sciences
Americans
100%
Prevalence
100%
Nutrition Policy
100%
Biochemistry, Genetics and Molecular Biology
Overall Survival
100%
Cancer Staging
50%
Cohort Study
25%
Prevalence
25%